当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析

华森制药

(002907)

  

流通市值:48.86亿  总市值:68.03亿
流通股本:3.00亿   总股本:4.18亿

华森制药(002907)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.68亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益171003.73万元,未分配利润71859.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产199770.08万元,负债28766.35万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入625,912,023.87441,913,009.17238,944,153.42774,819,866.89
营业总成本557,825,404.58385,855,057.45189,330,193.11699,830,140.66
其他经营收益
营业利润105,996,120.4775,512,477.6149,521,445.8993,800,589.5
利润总额89,546,089.2862,122,793.4649,301,337.6293,441,938.69
净利润67,918,133.1752,286,443.0240,355,212.3876,730,225.12
每股收益
其他综合收益-49,336.4-17,736.58-6,070.86244,061.74
综合收益总额67,868,796.7752,268,706.4440,349,141.5276,974,286.86
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,089,026,686.71,088,649,343.411,091,355,563.011,031,344,511.28
非流动资产:
非流动资产合计908,674,080.35932,083,668.02862,206,829.46886,205,077.72
资产总计1,997,700,767.052,020,733,011.431,953,562,392.471,917,549,589
流动负债:
流动负债合计233,467,375.39256,630,165.59209,944,378.22212,034,140.92
非流动负债:
非流动负债合计54,196,087.755,244,436.1743,120,927.1545,517,169.7
负债合计287,663,463.09311,874,601.76253,065,305.37257,551,310.62
所有者权益(或股东权益):
归属于母公司股东权益合计1,688,745,803.431,684,759,062.71,700,497,087.11,659,998,278.38
股东权益合计1,710,037,303.961,708,858,409.671,700,497,087.11,659,998,278.38
负债和股东权益合计1,997,700,767.052,020,733,011.431,953,562,392.471,917,549,589
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计638,169,723.83423,898,088.77191,675,253.51799,973,405.6
经营活动现金流出小计613,377,303.96396,371,750.13169,814,310.46638,206,596.58
经营活动产生的现金流量净额24,792,419.8727,526,338.6421,860,943.05161,766,809.02
投资活动产生的现金流量:
投资活动现金流入小计561,849,047.49231,781,185.5121,203,411.52348,531,606.4
投资活动现金流出小计698,444,809.22404,232,394.94302,374,756.73455,741,063.7
投资活动产生的现金流量净额-136,595,761.73-172,451,209.44-181,171,345.21-107,209,457.3
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计41,600,936.8726,943,089.8728,80035,634,044.72
筹资活动产生的现金流量净额-41,600,936.87-26,943,089.87-28,800-35,634,044.72
汇率变动对现金及现金等价物的影响-179,691.37-131,580.48-136,374.9563,769.26
现金及现金等价物净增加额-153,583,970.1-171,999,541.15-159,475,577.1118,987,076.26
期末现金及现金等价物余额302,967,925.3284,552,354.25297,077,352.27456,551,895.4
补充资料:
现金及现金等价物的净增加额--171,999,541.15-18,987,076.26
TOP↑